The need for identification or quantification of proteins triggered the development of respective detection units.
Several strategies exist for the metabolic labeling for the relative quantification of proteins, depending on the experimental system of interest.
Relative quantification of proteins from different samples was achieved by dimethyl isotope labeling and MS according to previously published methods (Boersema et al., 2008; Boersema et al., 2009).
Biopharmaceutical companies can now achieve advanced levels of specificity, sensitivity, and speed with these specialized analytical workflow solutions for the characterization and quantification of proteins.
With improvements in the MS platforms, the proteomics research has grown substantially from simply identifying proteins present in a clinical sample to the capability for absolute and relative quantification of proteins by either LC-MS/MS or targeted proteomics.
The resulting peptides were analyzed by LC-MS/MS for identification and quantification of proteins.
Improved purification, solubilization, and quantification of proteins spotted on the microarray would likely make this a more reliable assay.
This study was limited by a relatively small sample size, the sensitivity of the proteomic technique, and challenges in the quantification of proteins.
A representative experiment out of three performed is shown in Fig. 6, panel A. Quantification of proteins have been performed by densitometry autoradiography films.
A feature of the IPAS platform is that extensive fractionation allows de-complexing of the samples into individual fractions to allow identification and quantification of proteins present in the plasma over 6 7 orders of magnitude [16], [19].
The quantification of proteins from dialysates was rather inefficient.
